Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFLX.L Regulatory News (FLX)

  • There is currently no data for FLX

SOLARWINDS MSP APPOINTS FALANX

19 Sep 2018 07:00

RNS Number : 1832B
Falanx Group Limited
19 September 2018
ย 

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

ย 

Falanx Group Limited

("Falanx" or "the Company")

ย 

SOLARWINDS MSP APPOINTS FALANX AS ITS FIRST THREAT MONITORING SERVICE PROVIDER FOR THE UK AND SOUTH AFRICA

ย 

Falanx Group Ltd ("Falanx", AIM:FLX), the global cybersecurity and intelligence provider, is proud to announce it has been selected by SolarWinds MSP-a global leader in delivering comprehensive, scalable IT service management solutions to IT solution providers and managed service providers (MSPs)-as the first SolarWindsยฎ Threat Monitoring Service Providerโ„ข (TMSPโ„ข) for the UK and South Africa.

ย 

In this role, Falanx will support SolarWinds MSP as they look to help enable their MSP customers to leverage more advanced security services. Specifically, Falanx will serve as a threat monitoring service Provider for the delivery and support of SolarWinds Threat Monitoring Serviceโ„ข-which is designed to help enable proactive security monitoring-in conjunction with Falanx's combined cybersecurity services to MSPs.

ย 

SolarWinds is a leading provider of powerful and affordable IT infrastructure management software. Targeted for MSPs, the SolarWinds MSP product portfolio delivers broad, scalable IT service management solutions that integrate layered security, collective intelligence, and smart automation.

ย 

Falanx will meet SolarWinds MSP and clients at customer conferences in Manchester and London, UK, November 2018; Cape Town and Johannesburg, South Africa, November 2018; and the Empower MSP event in Scottsdale, Arizona, USA, 18 - 19 September 2018 to describe and discuss the delivery of combined security services and technology to the attendant SolarWinds MSP clients and partners.

ย 

ย 

Mike Read, chairman and chief executive officer of Falanx, commented:

ย 

"We are extremely proud to be associated with SolarWinds, who, having made the strategic decision to launch the Threat Monitoring Service Program, have appointed Falanx as one of their first threat monitoring service providers. As an MSSP, Falanx has been selling through MSPs for the last two years, enabling them to offer our portfolio of security services directly to their customers. This program is a transformational event for our business, and potentially accelerates our access to the UK and South Africa MSP communities through a new MDR service, which complements our current MidGARD offering."

ย 

ย 

Enquiries:

ย 

Falanx Group Limited

Mike Read, Chief Executive Officer

ย 

ย 

www.falanx.com

ย 

SPARK Advisory Partners Limited

Nominated Adviser

Matt Davis / James Keeshan

ย 

ย 

+44 (0) 203 368 3551

ย 

Turner Pope Investments (TPI) Ltd

Broker

Ben Turner / James Pope

ย 

+44 (0) 203 621 4120

ย 

IFC Advisory Ltd

Financial PR & IR

Graham Herring

Miles Nolan

Zach Cohen

+44 (0) 203 934 6630

ย 

About Falanx

Falanx Group Limited, is a global intelligence and cyber defence provider working with blue chip and government clients. It operates the MidGARD cyber monitoring platform for corporate and governmental customers which utilises a combination of proprietary and third-party processes and technologies. For more information: http://www.falanx.com/

ย 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
ย 
END
ย 
ย 
MSCUWAKRWUAKAAR
Date   Source Headline
9th Dec 20222:42 pmRNSHolding(s) in Company
8th Dec 20224:29 pmRNSResult of AGM
8th Dec 20227:00 amRNSInterim Results
24th Nov 20225:17 pmRNSHolding(s) in Company
15th Nov 20225:56 pmRNSNotice of AGM
18th Oct 20227:00 amRNSDirectorate Change
29th Sep 20227:00 amRNSFinal Results
20th Sep 20227:00 amRNSHolding(s) in Company
5th Sep 20224:53 pmRNSHolding(s) in Company
4th Aug 20222:06 pmRNSSecond Price Monitoring Extn
4th Aug 20222:00 pmRNSPrice Monitoring Extension
4th Aug 202211:05 amRNSSecond Price Monitoring Extn
4th Aug 202211:00 amRNSPrice Monitoring Extension
4th Aug 20227:00 amRNSTrading Update
9th May 20227:00 amRNSPartnership to Provide M-EDR to UK Customers
8th Apr 20224:06 pmRNSHolding(s) in Company
6th Apr 202211:59 amRNSHolding(s) in Company
1st Apr 20227:00 amRNSChange of Adviser
30th Mar 20222:44 pmRNSDirector/PDMR Shareholding
23rd Mar 202212:59 pmRNSDirector/PDMR Shareholding
10th Feb 202211:11 amRNSDirector/PDMR Shareholding
24th Jan 20227:00 amRNSDirector/PDMR Shareholding
19th Jan 20225:20 pmRNSHolding(s) in Company
19th Jan 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 202111:14 amRNSResult of AGM
7th Dec 20217:00 amRNSInterim Results
16th Nov 20212:10 pmRNSNotice of AGM
29th Oct 20211:57 pmRNSExercise of Options, TVR and PDMR dealing
27th Oct 20219:03 amRNSDirector/PDMR Shareholding
26th Oct 20217:00 amRNSDirector/PDMR Shareholding
25th Oct 20213:25 pmRNSExercise of Options and TVR
13th Oct 202111:06 amRNSSecond Price Monitoring Extn
13th Oct 202111:00 amRNSPrice Monitoring Extension
13th Oct 20217:00 amRNSTrading update and BOOST&Co loan facility update
6th Oct 20214:41 pmRNSSecond Price Monitoring Extn
6th Oct 20214:35 pmRNSPrice Monitoring Extension
6th Oct 20212:43 pmRNSSale of Assynt for £4.6 million
4th Oct 20217:00 amRNSFalanx Launch Mass Market Security Assessment Tool
29th Sep 20217:00 amRNSAnnual results for the year ended 31 March 2021
18th Aug 20217:01 amRNSGrant of share options
18th Aug 20217:00 amRNSTrading Update & New Loan Facility
9th Jul 20219:07 amRNSHolding(s) in Company
29th Apr 20217:00 amRNSCancellation of unapproved Share Options
1st Apr 20217:00 amRNSIssue of Equity and TVR
26th Feb 20213:31 pmRNSResult of GM
10th Feb 20212:03 pmRNSPublication of Circular & Notice of GM
8th Feb 202111:05 amRNSSecond Price Monitoring Extn
8th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSContract Wins and Covid Business Interruption Loan
18th Jan 20212:06 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.